242
Participants
Start Date
April 30, 2015
Primary Completion Date
April 30, 2019
Study Completion Date
June 30, 2019
Lacosamide Tablet
"* Active Substance: Lacosamide~* Pharmaceutical Form: Film-coated Tablet~* Concentration: 50 mg~* Route of Administration: Oral use"
Lasosamide Oral Solution
"* Active Substance: Lacosamide~* Pharmaceutical Form: Oral Solution~* Concentration: 10 mg/ml~* Route of Administration: Oral use"
Placebo Tablet
"* Active Substance: Placebo~* Pharmaceutical Form: Film-coated Tablet~* Concentration: 50 mg~* Route of Administration: Oral use"
Placebo Oral Solution
"* Active Substance: Placebo~* Pharmaceutical Form: Oral Solution~* Concentration: 10 mg/ml~* Route of Administration: Oral use"
Sp0982 043, New York
Sp0982 010, Waldorf
Sp0982 007, Bethesda
Sp0982 011, Jacksonville
Sp0982 013, Panama City
Sp0982 042, Wellington
Sp0982 002, Port Charlotte
Sp0982 028, Alabaster
Sp0982 023, Madison
Sp0982 025, Golden Valley
Sp0982 021, Peoria
Sp0982 045, Springfield
Sp0982 029, St Louis
Sp0982 009, New Orleans
Sp0982 005, Little Rock
Sp0982 050, Greenville
Sp0982 034, Houston
Sp0982 047, San Antonio
Sp0982 038, San Antonio
Sp0982 053, Austin
Sp0982 035, Denver
Sp0982 031, Colorado Springs
Sp0982 015, Boise
Sp0982 008, Santa Monica
Sp0982 018, Irvine
Sp0982 027, Renton
Sp0982 036, Danbury
Sp0982 981, Parkville
Sp0982 980, Chatswood
Sp0982 985, Heidelberg
Sp0982 986, Parkville
Sp0982 201, Brussels
Sp0982 202, Ghent
Sp0982 200, Leuven
Sp0982 181, Curitiba
Sp0982 180, Florianópolis
Sp0982 186, Passo Fundo
Sp0982 185, Porto Alegre
Sp0982 188, Rio de Janeiro
Sp0982 183, São Paulo
Sp0982 184, São Paulo
Sp0982 500, Blagoevgrad
Sp0982 501, Sofia
Sp0982 971, Beijing
Sp0982 976, Changchun
Sp0982 975, Chongqing
Sp0982 097, Fuzhou
Sp0982 973, Hangzhou
Sp0982 972, Shanghai
Sp0982 550, Ostrava Poruba
Sp0982 553, Prague
Sp0982 556, Prague
Sp0982 552, Zlín
Sp0982 255, Bron
Sp0982 252, Lille
Sp0982 251, Nancy
Sp0982 250, Rennes
Sp0982 305, Berlin
Sp0982 303, Erlangen
Sp0982 314, Freiburg im Breisgau
Sp0982 311, Marburg
Sp0982 302, München
Sp0982 600, Budapest
Sp0982 603, Szeged
Sp0982 850, Rehovot
Sp0982 851, Tel Litwinsky
Sp0982 351, Torino
Sp0982 907, Asaka
Sp0982 906, Fukuoka
Sp0982 910, Gifu
Sp0982 903, Hamamatsu
Sp0982 902, Hiroshima
Sp0982 913, Itami
Sp0982 912, Kagoshima
Sp0982 914, Kodaira
Sp0982 909, Kokubunji
Sp0982 901, Niigata
Sp0982 911, Ōmura
Sp0982 900, Sapporo
Sp0982 908, Shinjuku-Ku
Sp0982 904, Shizuoka
Sp0982 161, Guadalajara
Sp0982 657, Częstochowa
Sp0982 655, Gdansk
Sp0982 658, Gdynia
Sp0982 652, Gliwice
Sp0982 651, Katowice
Sp0982 653, Katowice
Sp0982 654, Katowice
Sp0982 656, Tyniec Mały
Sp0982 650, Warsaw
Sp0982 659, Warsaw
Sp0982 451, Lisbon
Sp0982 704, Iași
Sp0982 707, Iași
Sp0982 700, Timișoara
Sp0982 750, Kazan'
Sp0982 758, Pyatigorsk
Sp0982 755, Saint Petersburg
Sp0982 756, Saint Petersburg
Sp0982 752, Samara
Sp0982 753, Smolensk
Sp0982 757, Yekaterinburg
Sp0982 821, Bardejov
Sp0982 823, Hlohovec
Sp0982 940, Daegu
Sp0982 941, Seoul
Sp0982 944, Seoul
Sp0982 402, Barcelona
Sp0982 406, Córdoba
Sp0982 407, Madrid
Sp0982 404, Málaga
Sp0982 403, Seville
Sp0982 961, Taichung
Sp0982 960, Taipei
Collaborators (1)
Pharmaceutical Research Associates
OTHER
UCB BIOSCIENCES, Inc.
INDUSTRY